Scientific article
French

Ostéonécrose des maxillaires et bisphosphonates

Published inRevue médicale suisse, vol. 1, no. 39, p. 2537-2540,2542-3
Publication date2005
Abstract

Widely prescribed, bisphosphonates inhibit bone resorption. They are not metabolised and have long half-lives. Two cases of osteonecrosis of the jaws have recently been attributed to bisphosphonates at the University Hospital of Geneva. The recent literature reveals more than a hundred similar cases throughout the world. Bone exposure appears spontaneously or after dental care. Treatment of the osteonecrosis is controversial and cure very difficult. This pathology is usually seen in patients on chemotherapy, steroids and i.v. bisphosphonates, but is sometimes seen with low-dose p.o. bisphosphonates. In view of the strong association between bisphosphonate therapy and osteonecrosis of the jaw, specialists have recommended dental and oral evaluation during bisphosphonate therapy as well as for several years after drug discontinuation.

Keywords
  • Age Factors
  • Diphosphonates/administration & dosage/adverse effects/therapeutic use
  • Drug Interactions
  • Humans
  • Infusions, Intravenous
  • Jaw/pathology
  • Osteonecrosis/chemically induced
  • Steroids/therapeutic use
Citation (ISO format)
JUNOD, Alain et al. Ostéonécrose des maxillaires et bisphosphonates. In: Revue médicale suisse, 2005, vol. 1, n° 39, p. 2537–2540,2542–3.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1660-9379
563views
1downloads

Technical informations

Creation18/08/2014 14:55:00
First validation18/08/2014 14:55:00
Update time14/03/2023 21:31:48
Status update14/03/2023 21:31:48
Last indexation30/10/2024 19:44:48
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack